1-3 of 3
Ravi Krishnadasan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role of Anakinra in the Management of Steroid Refractory High Grade Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after Anti-CD 19 CAR-T Cell Therapy, a Single Center Experience

Ulyana Dashkevych, Nishant Munugala, Sharad Khurana, Abhijeet Kumar, Krisstina L. Gowin, Akshay Amaraneni, Ravi Krishnadasan, Jeffrey J. Pu, Emmanuel Katsanis, Muhammad Husnain
Journal: Blood
Blood (2022) 140 (Supplement 1): 12753–12754.
https://doi.org/10.1182/blood-2022-168240
Published: 2022
Journal Articles

Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome

Amer M. Zeidan, Uma Borate, Daniel A. Pollyea, Andrew M. Brunner, Fernando Roncolato, Jacqueline S. Garcia, Robin J Filshie, Olatoyosi Odenike, Anne-Marie Watson, Ravi Krishnadasan, Ashish Bajel, Kiran Naqvi, Jiuhong Zha, Leah Hogdal, Ying Zhou, David Hoffman, Steve Kye, Guillermo Garcia-Manero
Journal: Blood
Blood (2021) 138 (Supplement 1): 537.
https://doi.org/10.1182/blood-2021-145646
Published: 2021
Journal Articles

Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting

Leila Jafari, Jubair Hussain, Ravi Krishnadasan, MD, Keri R Maher, DO, Faiz Anwer, MD, Emad Elquza, MD MBA, Christopher Campen, PharmD, Lauren Sanders, PharmD, Alyssa Henglefelt, PharmD, Alicia Ortega, PharmD, Ali McBride, PharmD,MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2153.
https://doi.org/10.1182/blood-2019-132121
Published: 2019